HTG Provides Update on Drug Discovery Partnering Initiative

TUCSON, Ariz. , April 25, 2023 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a platform-based life science tools and drug discovery company, today provided an update on partnering discussions for its drug discovery business unit.